O'Neill P, Jenkins T C, Stratford I J, Silver A R, Ahmed I, McNeil S S, Fielden E M, Adams G E
MRC Radiobiology Unit, Didcot, Oxon, UK.
Anticancer Drug Des. 1987 Apr;1(4):271-80.
The interaction of a series of nitroimidazole-aziridine radiosensitisers, as parent or radiation-reduced species, with plasmid DNA in aqueous solution at pH7 results in strand breakage. The efficiency of strand breakage substantially increases on reduction of the nitroimidazole analogues. The rate of production of strand breaks decreases on interaction with both parent and reduced nitroimidazole analogues as the aziridine moiety is deactivated through alkyl-substitution. These variations in efficiency are reflected in changes in the toxicity towards both oxic and hypoxic cells and in the decrease in toxicity with progressive substitution of the aziridine moiety. The stabilities of these nitroimidazoles in aqueous solution at pH7 have also been determined. However, these stabilities do not parallel the variations in the alkylating efficiency of DNA by the aziridine moiety. These results have been discussed in terms of the relative reactivities of the nitroimidazoles with plasmid DNA and their ability to act as cytotoxic agents, especially following bioreduction and how the findings may relate to the radiosensitising properties of these agents.
一系列硝基咪唑 - 氮丙啶放射增敏剂作为母体或辐射还原产物,在pH7的水溶液中与质粒DNA相互作用会导致链断裂。硝基咪唑类似物还原后,链断裂效率显著提高。当氮丙啶部分通过烷基取代失活时,与母体和还原的硝基咪唑类似物相互作用时,链断裂的产生速率降低。这些效率变化反映在对有氧和缺氧细胞毒性的变化以及随着氮丙啶部分逐渐取代毒性的降低上。还测定了这些硝基咪唑在pH7水溶液中的稳定性。然而,这些稳定性与氮丙啶部分对DNA的烷基化效率变化并不平行。已根据硝基咪唑与质粒DNA的相对反应活性及其作为细胞毒性剂的能力,特别是在生物还原后的能力,以及这些发现如何与这些药物的放射增敏特性相关,对这些结果进行了讨论。